Clínic Barcelona

A study identifies areas of the genome involved in the response to lithium in bipolar disorder

Researchers from Hospital Clínic, IDIBAPS, University of Barcelona (UB) and Mental Health Research Center (CIBERSAM), associated with  Institute of Health Carlos III (ISCIII), have taken part in an international study, published in the prestigious journal The Lancet, where a region of the genome involved in the response to lithium in bipolar disorder has been discovered. This study is the largest genetic analysis using GWAS (Genome-Wide Association Study) carried out regarding the response to this medication so far and included data from more than 2,500 patients with the disease.